Gubra AS (FRA:PI3) Owner Earnings per Share (TTM): 17.68 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PI3 Gubra AS FRA:PI3
76 GF Score
Price €41.06
GF Value €26.59
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Gubra AS Owner Earnings per Share (TTM)?

Gubra AS FRA:PI3 +4.75% 76 Owner Earnings per Share (TTM) is 17.68 as of Dec. 2025. GuruFocus rates FRA:PI3 with a GF Score™ of 76/100 and a GF Value™ of €26.59 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 213 Biotechnology companies, Gubra AS ranks better than 92.02% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Gubra AS does not have enough data to calculate Owner Earnings per Share (TTM), so as Price-to-Owner-Earnings ratio.


The historical rank and industry rank for Gubra AS's Owner Earnings per Share (TTM) or its related term are showing as below:

FRA:PI3' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.39   Med: 2.76   Max: 4.08
Current: 2.39


During the past 6 years, the highest Price-to-Owner-Earnings ratio of Gubra AS was 4.08. The lowest was 2.39. And the median was 2.76.


FRA:PI3's Price-to-Owner-Earnings is ranked better than
92.02% of 213 companies
in the Biotechnology industry
Industry Median: 23.98 vs FRA:PI3: 2.39

Gubra AS's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was €-0.90. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.49. It's PE Ratio (TTM) ratio for today is At Loss.

Gubra AS's EPS without NRI for the six months ended in Jun. 2026 was €-0.90. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.47. It's PE Ratio without NRI ratio for today is At Loss.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by FactSet. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Gubra AS Owner Earnings per Share (TTM) Related Terms


Gubra AS Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Gubra AS's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS Owner Earnings per Share (TTM) Chart

Gubra AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial - - - - 13.88

Gubra AS Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial - - - - -

FRA:PI3 vs VRTX, REGN, MRNA: Owner Earnings per Share (TTM) Comparison

For the Biotechnology subindustry, Gubra AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS Price-to-Owner-Earnings vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Gubra AS's Price-to-Owner-Earnings falls into.


FRA:PI3
76GF Score
Gubra AS FRA:PI3
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gubra AS Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Gubra AS does not have enough data to calculate Owner Earnings per Share (TTM). Please check Wal-Mart Stores Inc, as your reference.

What does a Owner Earnings per Share (TTM) of 17.68 mean?
Gubra AS (FRA:PI3) has a Owner Earnings per Share (TTM) of 17.68 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Gubra AS. According to the industry distribution chart, Gubra AS ranks #17 out of 213 companies in the Biotechnology industry, placing it in the top 8%.
Is Gubra AS's Owner Earnings per Share (TTM) too high?
Gubra AS's current Owner Earnings per Share (TTM) is 17.68. The Biotechnology industry median Owner Earnings per Share (TTM) is 23.98. Gubra AS's value of 17.68 is 26.3% below this industry median. Based on the distribution chart, Gubra AS ranks #17 out of 213 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gubra AS has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Owner Earnings per Share (TTM) compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gubra AS ranks #17 out of 213 companies for Owner Earnings per Share (TTM). This places Gubra AS in the top 8% of its industry — outperforming the majority of peers. The industry median Owner Earnings per Share (TTM) is 23.98. Gubra AS's value of 17.68 is 26.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Biotechnology company?
The median Owner Earnings per Share (TTM) among Biotechnology companies is 23.98, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gubra AS's current Owner Earnings per Share (TTM) of 17.68 is 26.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Gubra AS. For the Biotechnology industry, the median Owner Earnings per Share (TTM) is 23.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gubra AS's current Owner Earnings per Share (TTM) is 17.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (FRA:PI3) is currently considered Significantly Overvalued. The stock's GF Value™ is €26.59, compared to a current price of €41.06 — trading 54.4% above its estimated fair value. The current Owner Earnings per Share (TTM) is 17.68 and 26.3% below the Biotechnology industry median of 23.98. Gubra AS's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Gubra AS (FRA:PI3), the current Owner Earnings per Share (TTM) is 17.68 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (FRA:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be overvalued. The current stock price of €41.06 is trading 54.4% above its estimated GF Value™ of €26.59. GuruFocus considers Gubra AS to be Significantly Overvalued.

Key valuation signals for FRA:PI3:

  • Owner Earnings per Share (TTM): 17.68
  • GF Value™: €26.59 vs. price of €41.06 (54.4% above fair value)
  • GF Score™: 76/100 with 4 warning signs
  • Industry Position: 26.3% below the Biotechnology median (#17 of 213)

No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
76GF Score

Get the complete analysis for FRA:PI3

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.06
Price
€26.59
GF Value